Clinical Trial Update: Citadel Embolization Device Study [NA]

View source ↗

Summary

Citadel Embolization Device trial for unruptured wide-neck intracranial aneurysms, sponsored by Stryker Neurovascular, is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm
• Unruptured Intracranial Aneurysm

Snippet

Sponsor: Stryker Neurovascular | Conditions: Unruptured Wide-neck Aneurysms | NA | Status: ACTIVE_NOT_RECRUITING